Literature DB >> 25905468

9-Hydroxycanthin-6-one, a β-Carboline Alkaloid from Eurycoma longifolia, Is the First Wnt Signal Inhibitor through Activation of Glycogen Synthase Kinase 3β without Depending on Casein Kinase 1α.

Kensuke Ohishi1, Kazufumi Toume1, Midori A Arai1, Takashi Koyano2, Thaworn Kowithayakorn3, Takamasa Mizoguchi1, Motoyuki Itoh1, Masami Ishibashi1.   

Abstract

Wnt signaling regulates various processes such as cell proliferation, differentiation, and embryo development. However, numerous diseases have been attributed to the aberrant transduction of Wnt signaling. We screened a plant extract library targeting TCF/β-catenin transcriptional modulating activity with a cell-based luciferase assay. Activity-guided fractionation of the MeOH extract of the E. longifolia root led to the isolation of 9-hydroxycanthin-6-one (1). Compound 1 exhibited TCF/β-catenin inhibitory activity. Compound 1 decreased the expression of Wnt signal target genes, mitf and zic2a, in zebrafish embryos. Treatment of SW480 cells with 1 decreased β-catenin and increased phosphorylated β-catenin (Ser 33, 37, Tyr 41) protein levels. The degradation of β-catenin by 1 was suppressed by GSK3β-siRNA, while compound 1 decreased β-catenin even in the presence of CK1α-siRNA. These results suggest that 1 inhibits Wnt signaling through the activation of GSK3β independent of CK1α.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25905468     DOI: 10.1021/acs.jnatprod.5b00153

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  10 in total

Review 1.  Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale.

Authors:  Michael A McCoy; Dominique Spicer; Neil Wells; Kurt Hoogewijs; Marc Fiedler; Matthias G J Baud
Journal:  J Med Chem       Date:  2022-05-17       Impact factor: 8.039

2.  Investigation of effective natural inhibitors for starch hydrolysing enzymes from Simaroubaceae plants by molecular docking analysis and comparison with in-vitro studies.

Authors:  Kirana P Mugaranja; Ananda Kulal
Journal:  Heliyon       Date:  2022-05-02

3.  Triazole-Based Inhibitors of the Wnt/β-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice.

Authors:  Obinna N Obianom; Yong Ai; Yingjun Li; Wei Yang; Dong Guo; Hong Yang; Srilatha Sakamuru; Menghang Xia; Fengtian Xue; Yan Shu
Journal:  J Med Chem       Date:  2019-01-10       Impact factor: 7.446

Review 4.  WNT Signaling in Cardiac and Vascular Disease.

Authors:  Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

Review 5.  Screening study of cancer-related cellular signals from microbial natural products.

Authors:  Masami Ishibashi
Journal:  J Antibiot (Tokyo)       Date:  2021-06-30       Impact factor: 2.649

6.  Cu-catalyzed mild and efficient oxidation of THβCs using air: application in practical total syntheses of perlolyrine and flazin.

Authors:  Bo Zheng; Tien Ha Trieu; Tian-Zhuo Meng; Xia Lu; Jing Dong; Qiang Zhang; Xiao-Xin Shi
Journal:  RSC Adv       Date:  2018-02-12       Impact factor: 4.036

Review 7.  Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials.

Authors:  Benjamin Lu; Brooke A Green; Jacqueline M Farr; Flávia C M Lopes; Terence J Van Raay
Journal:  Cancers (Basel)       Date:  2016-09-01       Impact factor: 6.639

Review 8.  Screening for natural products that affect Wnt signaling activity.

Authors:  Masami Ishibashi
Journal:  J Nat Med       Date:  2019-05-30       Impact factor: 2.343

9.  Novel β-carbolines inhibit Wnt/β-catenin signaling.

Authors:  L Kong; B Mao; H Zhu; Y Li
Journal:  Cell Death Dis       Date:  2015-11-19       Impact factor: 8.469

10.  Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy.

Authors:  Jiang-Jiang Qin; Wei Wang; Xin Li; Hemantkumar Deokar; John K Buolamwini; Ruiwen Zhang
Journal:  Front Pharmacol       Date:  2018-01-17       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.